Marcel E. Curlin - Concepedia

Author

Marcel E. Curlin

Also Known As

Aurelio Cruz-Valdez, Curlin, Marcel E., Fikadu G. Tafesse, Janet M. McNicholl, M Curlin, M. Curlin, M. E. Curlin, Marcel Curlin, Marcel E Curlin, Marcel E. Curlin

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Ministry of Public Health Centers for Disease Control and Prevention Oregon Health & Science University University of Washington Fred Hutch Cancer Center

About

Marcel E. Curlin is an author at Ministry of Public Health specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	2.4K
2	Epidemiology	8	8	363
3	Public Health	4	4	1.6K
4	Social Sciences	3	3	120
5	Natural Sciences	1	1	23

Marcel E. Curlin

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial Kachit Choopanya, Michael Martin, Pravan Suntharasamai, The Lancet Sexual HealthPreventive MedicineHiv/aids CounsellingTreatment And PreventionGlobal Health	2013	1.5K
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants Timothy A. Bates, Savannah K. McBride, Hans C. Leier, Science Immunology VaccinationVaccine DevelopmentSars-cov-2 InfectionVaccine TargetHumoral Response	2022	329
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum Timothy A. Bates, Hans C. Leier, Zoë L. Lyski, Nature Communications	2021	130
Human Immunodeficiency Virus Type 1<i>env</i>Evolves toward Ancestral States upon Transmission to a New Host Joshua T. Herbeck, David C. Nickle, Gerald H. Learn, Journal of Virology	2006	109
Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples Timothy A. Bates, Hans C. Leier, Zoë L. Lyski, JAMA ImmunologyVaccine HesitancyCovid-19Preventive MedicineBnt162b2 Vaccine	2021	107
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection Timothy A. Bates, Savannah K. McBride, Bradie Winders, JAMA	2021	106
The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs Michael Martin, Suphak Vanichseni, Pravan Suntharasamai, AIDS	2015	102
Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes Yen T. Duong, Reshma Kassanjee, Alex Welte, PLoS ONE	2015	96
HIV-1 Envelope Subregion Length Variation during Disease Progression Marcel E. Curlin, Rafael Zioni, Stephen E. Hawes, PLoS Pathogens Chronic IllnessDisease ProgressionMedicineHuman RetrovirusImmunology	2010	92
Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses Yi Liu, Marcel E. Curlin, Kurt Diem, Virology Virus StructureHuman RetrovirusPathogenesisGlycobiologyImmunology	2008	80

Page 1